Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Arboviral Encephalitis

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

Encephalitis l: Introduction

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Substance use stigma mechanisms associated with greater depressive symptoms, substance use-related problems, and lower behavioral activation.

Addictive behaviors reports·2026

Same author

Helping Peer Specialists Succeed: Lessons from a Statewide Training Program.

Research square·2026

Same author

HIV-Stigmatizing Beliefs and Attitudes as a Barrier to Early PrEP Care Continuum Engagement Among People Who Inject Drugs.

AIDS and behavior·2026

Same author

Do US Adults View Drug and Alcohol Addiction as a Health Condition?

Journal of addiction medicine·2026

Same author

Development and Validation of a Provider-Specific Anticipated Stigma Scale for People Who Inject Drugs.

AIDS and behavior·2026

Same author

Development and psychometric evaluation of two substance use disorder knowledge scales.

Drug and alcohol dependence·2026

Same journal

Cumulative adverse childhood experiences and parent-reported allergic conditions and asthma among U.S. children: A nationally representative study.

The American psychologist·2026

Same journal

Natural disaster, social cohesion, and prosociality: A natural experiment.

The American psychologist·2026

Same journal

Practice guidelines regarding psychologists' involvement in pharmacological issues.

The American psychologist·2026

Same journal

International Competences for Undergraduate Psychology (ICUP): A constructive shift for psychology?

The American psychologist·2026

Same journal

Two dimensions of access: Availability and affordability of mental health care across the United States.

The American psychologist·2026

Same journal

Revisiting secondary antisemitism: Antisemitism as a cause, not a consequence, of ingroup-serving Holocaust distortions.

The American psychologist·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2026

Preparation of Complaint Matrices for Quantifying Cellular Contraction

Preparation of Complaint Matrices for Quantifying Cellular Contraction

Published on: December 14, 2010

Patrick W. Corrigan (1956-2026).

Amy C Watson¹, Valerie A Earnshaw², Jonathon Larson³

¹Wayne State University.

The American Psychologist

|April 9, 2026

Summary

This summary is machine-generated.

This abstract memorializes Patrick W. Corrigan, a leading expert in psychiatric disability and mental health equity. His pioneering research addressed mental illness stigma and health disparities, advocating for community-based participatory research.

More Related Videos

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films

Published on: June 26, 2015

3D Printing and In Situ Surface Modification via Type I Photoinitiated Reversible Addition-Fragmentation Chain Transfer Polymerization

3D Printing and In Situ Surface Modification via Type I Photoinitiated Reversible Addition-Fragmentation Chain Transfer Polymerization

Published on: February 18, 2022

Related Experiment Videos

Last Updated: May 23, 2026

Preparation of Complaint Matrices for Quantifying Cellular Contraction

Preparation of Complaint Matrices for Quantifying Cellular Contraction

Published on: December 14, 2010

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films

Microfluidic Genipin Deposition Technique for Extended Culture of Micropatterned Vascular Muscular Thin Films

Published on: June 26, 2015

3D Printing and In Situ Surface Modification via Type I Photoinitiated Reversible Addition-Fragmentation Chain Transfer Polymerization

3D Printing and In Situ Surface Modification via Type I Photoinitiated Reversible Addition-Fragmentation Chain Transfer Polymerization

Published on: February 18, 2022

Area of Science:

Psychiatry
Public Health
Health Equity

Background:

Patrick W. Corrigan (1956-2026) was an internationally recognized expert.
His work focused on psychiatric disability, rehabilitation, stigma, and mental health equity.
He pioneered research into the nature, causes, and consequences of mental illness stigma.

Purpose of the Study:

To memorialize the contributions of Patrick W. Corrigan.
To highlight his pioneering research on mental illness stigma and health disparities.
To acknowledge his work in community-based participatory research and mentorship.

Main Methods:

Community-based participatory research (CBPR) was employed.
Research focused on peer navigators for individuals with psychiatric disabilities.
Interventions promoted healthy lifestyle behaviors among this population.

Main Results:

Corrigan's research advanced understanding of mental illness stigma.
His work contributed to strategies reducing health disparities.
His Chicago Health Disparities Center fostered community engagement.

Conclusions:

Corrigan's legacy includes significant advancements in psychiatric disability research.
His openness about personal mental health struggles inspired others.
He was a dedicated educator and mentor, shaping numerous careers.